<DOC>
	<DOCNO>NCT01630213</DOCNO>
	<brief_summary>The VITamin D OmegA-3 TriaL ( VITAL ; NCT 01169259 ) randomize clinical trial 20,000 U.S. men woman investigate whether take daily dietary supplement vitamin D3 ( 2000 IU ) fish oil ( 1 gram omega-3 fatty acid ) reduces risk develop cancer , heart disease , stroke people prior history illness . This ancillary study ( VITAL-Echo ) conduct among participant VITAL examine whether vitamin D compare placebo : ( 1 ) reduces leave ventricular ( LV ) mass elderly individual measure 2-dimensional echocardiography ( 2 ) improve LV systolic diastolic function measure tissue Doppler echocardiography .</brief_summary>
	<brief_title>Impact Vitamin D Supplementation Cardiac Structure Function</brief_title>
	<detailed_description>Recognition biological effect vitamin D cardiovascular function grow . The main objective parent trial ( VITAL ) evaluate effect vitamin D cardiac event focus atherothrombotic event specifically address vitamin D effect LV mass . In ambulatory individual , LV mass key cardiac structural feature increase LV mass frequently accompany diastolic dysfunction . This study leverage exist infrastructure parent VITAL trial perform cardiac image study subset subject randomize vitamin D3 ( n=500 ) placebo ( n=500 ) . Echocardiography noninvasive , widely accessible tool evaluate cardiac structure function . Cardiac echo image visit take place baseline ( pre-randomization ) , 2 year , Massachusetts General Hospital ( MGH ) . The acronym VITAL-Echo reflect link parent VITAL trial ancillary investigation vitamin D versus placebo LV mass function measure echocardiography . The effect fish oil supplementation parameter evaluate secondary endpoint , thereby take advantage factorial design parent trial .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Participants VITAL ( NCT 01169259 ) meet follow criterion eligible participate ancillary study : Inclusion : Willingness participate ancillary study VITAL undergo cardiac echocardiography ( baseline 3 year ) sign inform consent participate ancillary study Live great Boston area ( within 60 mile MGH ) Exclusion : Have pacemaker , prosthetic valve ( ) , surgical wire device could alter echocardiographic image finding .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Vitamin D3</keyword>
	<keyword>Left ventricular mass</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Left ventricular systolic diastolic function</keyword>
</DOC>